This website uses cookies to enhance the user experience.
||
A

AMGEN AB NORGE NORSK AVDELING AV UTENLANDSK FORETAK NUF982 725 038

Purchase and sale
Norwegian division of foreign business enterprise
Inkognitogata 33A 0256 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

AMGEN AB NORGE NORSK AVDELING AV UTENLANDSK FORETAK NUF

Operating
Distribusjon, salg, konsulent og markedsføringsvirksomhet av farmasøytiske produkter og teknisk medesinsk utstyr samt dertil hørende virksomhet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
TV

Tore Von Würden Petersen1974

Years since formation
26 years
since Dec 7, 2000
Type
Norwegian division of foreign business enterprise
VAT registered
Yes
Number of employees
30

Financials

Total operating income 2025
469,796,089
NOK
Annual total result 2025
16,748,777
NOK
Total equity 2025
93,516,430
NOK
Last update: Jul 15, 2026

Management

Management / administration

NameRoleShares
TV

Tore Von Würden Petersen

1974

Managing Director/CEO-

Board

NameRoleShares
A
AMGEN AB
Information about the Company in the Home Country-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
P
PWC TAX SERVICES AS
Accountant-
A
AZETS INSIGHT AS
Accountant-
E
ECIT SERVICES AS
Accountant-
Last update: Apr 27, 2026

Ownership

No available data

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
469,796,089
456,295,475
258,388,588
243,016,278
218,772,018
Annual Total Result
16,748,777
15,623,817
8,948,015
7,615,397
6,109,106
Total assets
252,485,330
175,308,498
149,720,871
129,083,189
111,417,546
Total liabilities
158,968,900
100,757,044
92,506,312
81,948,022
73,027,416
Total equity
93,516,430
74,551,455
57,214,559
47,135,167
38,390,129

P&L

Year20252024202320222021
Total operating income
469,796,089
456,295,475
258,388,588
243,016,278
218,772,018
Total operating costs
451,419,389
440,549,349
248,702,909
233,490,097
210,383,114
Operating result
18,376,699
15,746,126
9,685,679
9,526,181
8,388,903
Financial income/costs
3,891,942
4,899,253
2,156,622
750,156
20,866
Profit before tax
22,268,641
20,645,379
11,842,301
10,276,337
8,409,769
Total tax & extraordinary income/cost
5,519,864
5,021,562
2,894,286
2,660,940
2,300,663
Annual Total Result
16,748,777
15,623,817
8,948,015
7,615,397
6,109,106

Balance overview

Year20252024202320222021
Total fixed assets
65,510
85,099
113,464
410,256
481,530
Total current assets
252,419,820
175,223,400
149,607,407
128,672,933
110,936,016
Total assets
252,485,330
175,308,498
149,720,871
129,083,189
111,417,546
Short term debt
158,968,900
100,757,044
92,506,312
81,948,022
73,027,416
Long term debt
0
0
0
0
0
Total liabilities
158,968,900
100,757,044
92,506,312
81,948,022
73,027,416
Contributed capital
0
0
0
0
0
Retained earnings
93,516,430
74,551,455
57,214,559
47,135,167
38,390,129
Total equity
93,516,430
74,551,455
57,214,559
47,135,167
38,390,129
Total equity and liabilities
252,485,330
175,308,498
149,720,871
129,083,189
111,417,546

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods